drugset / Trial / NCT03268226
Functional Respiratory Imaging Study (FRI)
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the effect of inhaled extrafine CHF5993 pMDI on airway volumes, and resistance, by Functional Respiratory Imaging (FRI), in COPD patients
Timeline
- Start
- 2017-11-20
- Primary completion
- 2019-01-30
- Completion
- 2019-01-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Formoterol | Other / unclassified | 6 ug | Inhaled |
| Subject | Glycopyrronium | Unknown | 12.5 ug | Inhaled |
| Subject | beclomethasone dipropionate | Other / unclassified | 100 ug | Inhaled |